|
Volumn 158, Issue 5, 2014, Pages 971-972
|
Neutralizing the HIV reservoir
|
Author keywords
[No Author keywords available]
|
Indexed keywords
7 (3,5 DIMETHYL 4 ISOXAZOLYL) 1,3 DIHYDRO 8 METHOXY 1 [1 (2 PYRIDINYL)ETHYL] 2H IMIDAZO[4,5 C]QUINOLIN 2 ONE;
I BET 151;
NEUTRALIZING ANTIBODY;
UNCLASSIFIED DRUG;
VIRUS PROTEIN;
VORINOSTAT;
ANTIVIRAL THERAPY;
ARTICLE;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LATENT PERIOD;
NONHUMAN;
PRIORITY JOURNAL;
VIRUS CARRIER;
VIRUS ENVELOPE;
VIRUS LOAD;
VIRUS NEUTRALIZATION;
VIRUS REPLICATION;
ANIMAL;
DRUG EFFECTS;
GENETIC TRANSCRIPTION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
IMMUNOLOGY;
VIRUS LATENCY;
ANIMALS;
ANTIBODIES, NEUTRALIZING;
HIV INFECTIONS;
HIV-1;
HUMANS;
TRANSCRIPTION, GENETIC;
VIRUS LATENCY;
|
EID: 84907359983
PISSN: 00928674
EISSN: 10974172
Source Type: Journal
DOI: 10.1016/j.cell.2014.08.010 Document Type: Short Survey |
Times cited : (11)
|
References (10)
|